Affimed Logo
  • Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • Pipeline and Clinical Trials
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Innately Affimed
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Corporate Governance Affimed
    • Annual General Meeting 2023
    • Sustainability Affimed
    • Press Release Distribution
  • Careers
    • Culture
  • Contact
Menu

News and Events

See what’s new at Affimed

News

All categories
Earnings
Press Release
All years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Affimed Announces Second Quarter 2015 Financial Results and Corporate Update Conference Call

July 28, 2015

Affimed Added to Russell 2000® Index

June 30, 2015

Affimed Announces Opening of US Operations and Key US- based Hires

June 23, 2015

AbCheck and Pierre Fabre Pharmaceuticals Enter Into Strategic Research Partnership

June 17, 2015

Affimed ASCO Data Demonstrate Consistent Potency of NK- Cell-Engaging Combination Therapy with Checkpoint Modulators

May 29, 2015

Affimed ASCO Data for the CD33/CD3-TandAb Program Demonstrate that CD33 and CD3 binding affinities correlate with potent T-cell activation and cytotoxicity

May 29, 2015

Affimed to Present at the Jefferies 2015 Healthcare Conference – New York

May 27, 2015

Affimed Completes TandAb Development Candidate Activities Meeting Amphivena’s and Janssen’s Criteria and Achieves Milestone Ahead of Schedule

May 24, 2015

Affimed Reports Financial Results for First Quarter 2015

May 21, 2015

Affimed to Present Data at ASCO to Highlight Potency of NK- Cell-Engaging Combination Therapy with Checkpoint Modulators

May 13, 2015

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29

Events

All
Scientific
Investors

02Jun

ASCO Annual Meeting

June 2 - 6, 2023 (Chicago, US)

08Jun

EHA

June 8 - 11, 2023 (Frankfurt, Germany)

13Jun

17-ICML

June 13 - 17, 2023 (Lugano, Switzerland)

WebcastsMore events

Affimed GmbH
Technologiepark
Im Neuenheimer Feld 582
69120 Heidelberg, Germany

Phone: +49 (0)6221-6743-60
Fax: +49 (0)6221 6743-649
email hidden; JavaScript is required

  • Affimed Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Press Release Distribution
    • Corporate Governance
  • Careers
    • Culture

© 2023 Affimed GmbH

  • Data Protection
  • Imprint
  • Contact